Live: Will Axon Deliver Another Blowout Quarter After the Bell?

Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

624 Articles

Trey Thoelcke | Feb 17, 2014 at 7:05 AM EST

Biotech Buyout Bolsters Novartis Cancer Portfolio

Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…

Jon C. Ogg | Feb 13, 2014 at 10:40 AM EST

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good…

Jon C. Ogg | Jan 23, 2014 at 10:25 AM EST

Ariad Joins Rumor Mill: Hope May Trump Reality

Ariad Pharmaceuticals could be joining the ranks of the next big biotech acquisitions. The company fits the bill of many…

Trey Thoelcke | Dec 18, 2013 at 7:00 AM EST

Teva Secures Rights to Launch Generic Viagra

ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020,…

Jon C. Ogg | Nov 11, 2013 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Jon OggNow that we are mostly through earnings season and now that stocks have challenged all-time highs recently, investors and…

Jon C. Ogg | Nov 7, 2013 at 9:15 AM EST

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

courtesy Deere & Co.UBS has a list of stocks that investors may want to consider selling. They could even be…

Lee Jackson | Oct 24, 2013 at 9:00 AM EDT

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

courtesy of AOL, IncHeading into the fourth quarter of this year, investors who have been long the stock market are…

Jon C. Ogg | Oct 11, 2013 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 6:19 AM EDT

The Highest-Yielding Dividends That Are Safe to Hold

ThinkstockThe number of companies paying dividends in the S&P 500 is at a 15-year high. According to FactSet, just over…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Lee Jackson | Aug 26, 2013 at 8:30 AM EDT

Credit Suisse Highlights Stocks That Avoid Smoke and Mirror on Earnings

ThinkstockThe second-quarter earnings parade has all but come to a end. One conclusion that is painfully obvious to the equity…

Jon C. Ogg | Aug 5, 2013 at 8:05 AM EDT

Top Stock Holdings at Some of the Premier Hedge Funds

courtesy of Sprint Corp.In the past 30 years, the hedge fund industry has shown phenomenal growth. Initially formed as true…

Jon C. Ogg | Jul 9, 2013 at 6:43 PM EDT

Intrexon IPO Filing: Better DNA for Health Care, Food, Energy, Environment

ThinkstockIntrexon Corp. has filed its paperwork with the Securities and Exchange Commission to allow the company to come public in…

Jon C. Ogg | May 28, 2013 at 8:00 AM EDT

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013.…

1 … 32 33 34 35 36 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Ariad Joins Rumor Mill: Hope May Trump Reality

Teva Secures Rights to Launch Generic Viagra

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The Highest-Yielding Dividends That Are Safe to Hold

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Credit Suisse Highlights Stocks That Avoid Smoke and Mirror on Earnings

Top Stock Holdings at Some of the Premier Hedge Funds

Intrexon IPO Filing: Better DNA for Health Care, Food, Energy, Environment

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Live: Will Axon Deliver Another Blowout Quarter After the Bell?

Live: AppLovin Q1 Earnings Tonight. Can $APP See a Monster Rally From Here?

Live: Will IonQ’s Massive Run Continue After Q1 Earnings Tonight?

The smartphone era is ending the way it started: with Apple

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

The Sneaky International ETF That’s Quietly Outrunning the S&P 500 This Year

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

A $500,000 REIT Portfolio That Pays You Rent Without Owning a Single Property

The smartphone era is ending the way it started: with Apple

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

Eli Lilly : LLY

All Eli Lilly Articles

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Ariad Joins Rumor Mill: Hope May Trump Reality

Teva Secures Rights to Launch Generic Viagra

Top Analyst Upgrades and Downgrades: Twitter, Best Buy, Exxon and More

Stocks to Sell or Short: The Seven Least Preferred Stocks at UBS

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

The Highest-Yielding Dividends That Are Safe to Hold

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Credit Suisse Highlights Stocks That Avoid Smoke and Mirror on Earnings

Top Stock Holdings at Some of the Premier Hedge Funds

Intrexon IPO Filing: Better DNA for Health Care, Food, Energy, Environment

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Live: Will Axon Deliver Another Blowout Quarter After the Bell?

Live: AppLovin Q1 Earnings Tonight. Can $APP See a Monster Rally From Here?

Live: Will IonQ’s Massive Run Continue After Q1 Earnings Tonight?

The smartphone era is ending the way it started: with Apple

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

The Sneaky International ETF That’s Quietly Outrunning the S&P 500 This Year

Featured Reads

How Much Do You Really Need Invested to Replace an $80,000 Salary With Dividends?

A $500,000 REIT Portfolio That Pays You Rent Without Owning a Single Property